These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hyperprolactinemia induced by neuroleptics]. Lakartidningen; 2007 May 9-15; 104(19):1522. PubMed ID: 17550031 [No Abstract] [Full Text] [Related]
3. [Hyperprolactinemia in a child diagnosed with Asperger syndrome and hyperkinetic disorder treated with risperidone]. Monge Galindo L; Escosa García L; García Sánchez N; Ruiz-Lázaro PM An Pediatr (Barc); 2009 Jul; 71(1):86-7. PubMed ID: 19473900 [No Abstract] [Full Text] [Related]
4. Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection. Bai YM; Chen TT; Lin WK; Chang WH; Wu B; Hung CH; Chou P; Chen JY J Clin Psychopharmacol; 2007 Jun; 27(3):306-8. PubMed ID: 17502783 [No Abstract] [Full Text] [Related]
6. Risperidone in children with autism and serious behavioral problems. Valiquette G N Engl J Med; 2002 Dec; 347(23):1890-1; author reply 1890-1. PubMed ID: 12472071 [No Abstract] [Full Text] [Related]
7. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Keller R; Mongini F Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680 [TBL] [Abstract][Full Text] [Related]
9. Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Compton MT; Miller AH Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853 [TBL] [Abstract][Full Text] [Related]
10. [Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients]. Konarzewska B; Szulc A; Popławska R; Galińska B; Juchnowicz D Psychiatr Pol; 2008; 42(1):87-95. PubMed ID: 18567406 [TBL] [Abstract][Full Text] [Related]
11. Risperidone-induced hyperprolactinemia in an elderly woman. Bai YM; Ciu HJ; Guo ZZ Am J Psychiatry; 2002 Dec; 159(12):2112. PubMed ID: 12450970 [No Abstract] [Full Text] [Related]
12. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia. Kopecek M; Bares M; Horacek J; Mohr P Neuro Endocrinol Lett; 2006 Dec; 27(6):803-6. PubMed ID: 17187006 [TBL] [Abstract][Full Text] [Related]
13. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone. Lai YC; Chiou CC; Chen CH; Huang MC J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693 [No Abstract] [Full Text] [Related]
14. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone. Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641 [TBL] [Abstract][Full Text] [Related]
15. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives. Byerly M; Suppes T; Tran QV; Baker RA J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132 [TBL] [Abstract][Full Text] [Related]
16. The disparity of pharmacokinetics and prolactin study for risperidone long-acting injection. Peng PW; Huang MC; Tsai CJ; Pan CH; Chen CC; Chiu CC J Clin Psychopharmacol; 2008 Dec; 28(6):726-7; author reply 727-8. PubMed ID: 19011459 [No Abstract] [Full Text] [Related]